Stomatological approach to Sjögren's syndrome: Diagnosis, management and therapeutical timing

European Review for Medical and Pharmacological Sciences

Volumn 13, Issue 3, 2009, Pages 201-216

  Minozzi, Filippo ^a   Galli, M ^a   Gallottini, L ^a   Minozzi, M ^b   Unfer, V ^a  

^a Department of Odontostomatological Sciences   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Differential diagnoses; Lachrymal glands; Management; Odontostomatological approach; Odontostomatological treatment; Salivary glands; Sj gren's syndrome

Indexed keywords

ALPHA INTERFERON; AMPHETAMINE DERIVATIVE; ANETHOLE TRITHIONE; ANOREXIGENIC AGENT; ANTIHISTAMINIC AGENT; BETHANECHOL; BROMHEXINE; BRONCHODILATING AGENT; CARBACHOL; CEVIMELINE; CHOLINERGIC RECEPTOR STIMULATING AGENT; DECONGESTIVE AGENT; DIDANOSINE; DISOPYRAMIDE; DIURETIC AGENT; LA ANTIBODY; LITHIUM; MUCOLYTIC AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; OMEPRAZOLE; OXYBUTYNIN; PILOCARPINE; PRIMROSE OIL; PROTEINASE INHIBITOR; PYRIDOSTIGMINE; SALIVA SUBSTITUTE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

ABDOMINAL PAIN; ADULT; AUTOIMMUNE DISEASE; BLURRED VISION; BRADYCARDIA; DENTAL CARIES; DIAGNOSTIC APPROACH ROUTE; FEMALE; FLATULENCE; FLU LIKE SYNDROME; FLUSHING; GASTROINTESTINAL SYMPTOM; GINGIVITIS; HEADACHE; HEART PALPITATION; HISTOPATHOLOGY; HUMAN; HYPOTENSION; LACRIMAL GLAND; LACRIMATION; LUNG DISEASE; MALE; MIOSIS; NAUSEA; PERIODONTAL DISEASE; REFLEX TACHYCARDIA; REVIEW; RHEUMATOID ARTHRITIS; SALIVARY GLAND; SIDE EFFECT; SJOEGREN SYNDROME; SWEATING; SYSTEMIC LUPUS ERYTHEMATOSUS; TACHYCARDIA; THRUSH; URINARY FREQUENCY; VISUAL DISORDER; XEROPHTHALMIA; XEROSTOMIA;

ADULT; CRITICAL PATHWAYS; FEMALE; HUMANS; MALE; MIDDLE AGED; ORAL HYGIENE; PALLIATIVE CARE; PATIENT CARE TEAM; PREDICTIVE VALUE OF TESTS; SJOGREN'S SYNDROME; TIME FACTORS; TREATMENT OUTCOME; XEROPHTHALMIA; XEROSTOMIA;

EID: 68349097291     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. SUTCLIFFE N. Sjögren's syndrome. Medicine 2006; (34)11: 476-479.
2. SOAMES JV, SOUTHAM JC. Patologia orale. III ed. EMSI, Roma, 2005.
3. VENABLES PJ. Management of patients presenting with Sjögren's syndrome. Best Pract Res Clin Rheumatol 2006; 20: 791-807. (Pubitemid 44350119)
4. VENABLES PJW. Sjögren's syndrome. Best Pract Res Clin Rheumatol 2004; 18: 313-329.
5. KINDELAN SA, YEOMAN CM, DOUGLAS CWI, FRANKLIN C. A comparison of intraoral Candida carriage in Sjögren's syndrome patients with healthy xerostomic controls. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 85: 162-167. (Pubitemid 128031991)
6. PORTER SR, SCULLY C, HEGARTY AM. An update of the etiology and management of xerostomia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 97: 28-46.
7. FIELD EA, LONGMAN LP, BUCKNALL R, KAYE SB, HIGHAM SM, EDGAR WM. The establishment of a xerostomia clinic: a prospective study. Br J Oral Maxillofac Surg 1997; 35: 96-103.
8. RADFAR L, SHEA Y, FISCHER SH, SANKAR V, LEAKAN RA, BAUM BJ, PILLEMER SR. Fungal load and candidiasis in Sjögren's syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 96: 283-287.
9. ABRAHAM CM, AL-HASHIMI I, HAGHIGHAT N. Evaluation of the levels of oral Candida in patients with Sjögren's syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 86: 65-68.
10. SALOMONSSON S, WAHREN-HERLENIUS M. Local production of Ro/SSA and La/SSB autoantibodies in the target organ coincides with high levels of circulating antibodies in sera of patients with Sjögren's syndrome. Scand J Rheumatol 2003; 32: 79-82.
11. POURMAND N, WAHREN-HERLENIUS M, GUNNARSSON I, SVENUNGSSON E, LOFSTROM B, IOANNOU Y, ISENBERG DA, MAGNUSSON CG. Ro/SSA and La/SSB specific IgA autoantibodies in serum of patients with Sjögren's syndrome and systemic lupus erythematosus. Ann Rheum Dis 1999; 58: 623-629.
12. PATEL YI, MCHUGH NJ. Apoptosis-new clues to the pathogenesis of Sjögren's syndrome? Rheumatology 2000; 39: 119-121. (Pubitemid 30139343)
13. HANEJI N, NAKAMURA T, TAKIO K, YANAGI K, HIGASHIYAMA H, SAITO I, NOJI S, SUGINO H, HAYASHI Y. Identification of alpha-fodrin as a candidate autoantigen in primary Sjögren's syndrome. Science 1997; 276: 604-607.
14. WATERMAN SA, GORDON TP, RISCHMUELLER M. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome. Arthritis Rheum 2000; 43: 1647-1654.
15. ZANDBELT MM, VOGELZANGS J, VAN DE PUTTE LB, VAN VENROOUIJ WJ, VAN DEN HOOGEN FH. Anti-alpha-fodrin antibodies do not add much to the diagnosis of Sjögren's syndrome. Arthritis Res Ther 2004; 6: R33-R38.
16. KORDOSSIS T, PAIKOS S, ARONI K, KITSANTA P, DIMITRAKOPOULOS A, KAVOUKLIS E, ALEVIZOU V, KYRIAKI P, SKOPOULI FN, MOUTSOPOULOS HM. Prevalence of Sjögren's-like syndrome in a cohort of HIV-I-positive patients: descriptive pathology and immunopathology. Br J Rheumatol 1998; 37: 691-695. (Pubitemid 28375338)
17. GARRY RF, FERMIN CD, HART DJ, ALEXANDER SS, DONEHOWER LA, LUO-ZHANG H. Detection of a human intracisternal A-type retroviral particle antigenically related to HIV. Science 1990; 250: 1127-1129.
18. RIGBY SP, GRIFFITHS DJ, WEISS RA, VENABLES PJ. Human retrovirus-5 proviral DNA is rarely detected in salivary gland biopsy tissues from patients with Sjögren's syndrome. Arthritis Rheum 1997; 11: 2016-2021.
19. GREEN JE, HINRICHS SH, VOGEL J, JAY G. Exocrinopathy resembling Sjögren's syndrome in HTLV-I tax transgenic mice. Nature 1989; 341: 72-74.
20. HOLLSBERG P. Mechanism of T-cell activation by human T-cell lymphotropic virus type I. Microbiol Mol Biol Rev 1999; 63: 308-333. (Pubitemid 29264974)
21. HARLEY JB, REICHLIN M, ARNETT FC, ALEXANDER EL, BIAS WB, PROVOST TT. Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome. Science 1986; 232: 1145-1147.
22. IOANNIDIS JP, VASSILIOU VA, MOUTSOPOULOS HM. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjögren's syndrome. Arthritis Rheum 2002; 46: 741-747.
23. DELALEU N, JONSSON R, KOLLER MM. Sjögren's syndrome. Eur J Oral Sci 2005; 113: 101-113.
24. VITALI C, BOMBARDIERI S, MOUTSOPOULOS HM, BALESTRIERI G, BENCIVELLI W, BERNSTEIN RM, BJERRUM KB, BRAGA S, COLL J, DE VITA S, et al. Preliminary criteria for the classification of Sjögren's syndrome. Arthritis Rheum 1993; 36: 340-347.
25. VITALI C, BOMBARDIERI S, MOUTSOPOULOS HM, COLL J, GERLI R, HATRON PY, KATER L, KONTTINEN YT, MANTHORPE R, MEYER O, MOSCA M, OSTUNI P, PELLERITO RA, PENNEC Y, PORTER SR, RICHARDS A, SAUVEZIE B, SCHIØDT M, SCIUTO M, SHOENFELD Y, SKOPOULI FN, SMOLEN JS, SOROMENHO F, TISHLER M, WATTIAUX MJ, et al. Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. Ann Rheum Dis 1996; 55: 116-121. (Pubitemid 126422962)
26. VITALI C, BOMBARDIERI S, JONSSON R, MOUTSOPOULOS HM, ALEXANDER EL, CARSONS SE, et al; EUROPEAN STUDY GROUP ON CLASSIFICATION CRITERIA FOR SJÖGREN'S SYNDROME. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554-558.
27. VITALI C. Classification criteria for Sjögren's syndrome. Ann Rheum Dis 2003; 62: 94-95.
28. VAN BIJSTERVELD OP. Diagnostic tests in the sicca syndrome. Arch Ophthalmol 1969; 82: 10-14.
29. VAN BUSTERVELD OP. Diagnosis and differential diagnosis of keratoconjunctivitis sicca associated with tear gland degeneration. Clin Exp Rheumatol 1990; 8(Suppl. 5): 3-6.
30. CHISHOLM DM, MASON DK. Labial salivary gland biopsy in Sjögren's disease. J Clin Pathol 1968; 21: 656-660.
31. FRIEDLANDER MH. Ocular manifestations of Sjögren's syndrome: keratoconjunctivitis sicca. Rheum Dis Clin North Am 1992; 18: 591-608.
32. FOSTER HE, GILROY JJ, KELLY CA, HOWE J, GRIFFITHS ID. The treatment of sicca features in Sjögren's syndrome: a clinical review. BrJ Rheumatol 1994; 33: 278-282. (Pubitemid 24089781)
33. AMICO-ROXAS M, CAPUTI AP, DEL TACCA M. Farmacologia in odontoiatria. UTET, Torino (Italy), 2003.
34. BEROUKAS D, GOODFELLOW R, HISCOCK J, JONSSON R, GORDON TP, WATERMAN SA. Up-regulation of M3-muscarinic receptors in labial salivary gland acini in primary Sjögren's syndrome. Lab Invest 2002; 82: 203-210.
35. GAO J, CHA S, JONSSON R, OPALKO J, PECK AB. Detection of anti-type 3 muscarinic acetylcholine receptor autoantibodies in the sera of Sjögren's syndrome patients by use of a transfected cell line assay. Arthritis Rheum 2004; 50: 2615-2621.
36. BYMASTER FP, MCKINZIE DL, FELDER CC, WESS J. Use of M1-M5 muscarinic receptor knockout mice as novel tools to delineate the physiological roles of the muscarinic cholinergic system. Neurochem Res 2003; 28: 437-442. (Pubitemid 36314830)
37. GRISIUS MM. Salivary gland dysfunction: A review of systemic therapies. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 92: 156-162.
38. TSIFETAKI N, KITSOS G, PASCHIDES CA, ALAMANOS Y, EFTAXIAS V, VOULGARI PV, PSILAS K, DROSOS AA. Oral pilocarpine for the treatment of ocular symptoms in patients with Sjögren's syndrome: a randomised 12 week controlled study. Ann Rheum Dis 2003; 62: 1204-1207.
39. CUMMINS MJ, PAPAS A, KAMMER GM, FOX PC. Treatment of primary Sjögren's syndrome with low-dose human interferon alfa administered by the oromucosal route: combined phase III results. Arthritis Rheum 2003; 49: 585-593.